Without policy intervention to address average sales price-based challenges to biosimilar market sustainability, there is a ...

US v. Skrmetti undermined constitutional guardrails that guarantee rigorous assessment of medical justifications for policies limiting the rights of transgender people and women, creating a need and ...

Ryan N. Hansen, PharmD, PhD, is professor and chair of the Department of Pharmacy, and faculty in the CHOICE Institute, School of Pharmacy, University of Washington, and chief technology officer at ...

While recent fertility drug-related announcements by the Trump administration could result in savings for women—especially ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

The No Surprises Act has protected patients from surprise medical bills. However, the law’s incentives for insurers acting as ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

It is essential to weigh the report’s recommendations not only for their technical merit but also for their political ...

Health Affairs' Jeff Byers welcomes Allison Oakes, Chief Research Officer of Trilliant Health, to the pod to discuss ...

Language services are essential for health equity and good patient health outcomes, but recent executive actions threaten to ...

The North Carolina State Health Plan experience shows us that large, self-insured employers can work to bend the cost curve ...

For now, the most reasonable stance is watchful waiting: acknowledging the real problems WISeR seeks to address, recognizing ...